217 related articles for article (PubMed ID: 30134973)
1. Forward and reverse mutations in stages of cancer development.
Hu T; Kumar Y; Shazia I; Duan SJ; Li Y; Chen L; Chen JF; Yin R; Kwong A; Leung GK; Mat WK; Wu Z; Long X; Chan CH; Chen S; Lee P; Ng SK; Ho TYC; Yang J; Ding X; Tsang SY; Zhou X; Zhang DH; ; Zhou EX; Xu L; Poon WS; Wang HY; Xue H
Hum Genomics; 2018 Aug; 12(1):40. PubMed ID: 30134973
[TBL] [Abstract][Full Text] [Related]
2. Genomic subtyping of liver cancers with prognostic application.
Wu Z; Long X; Tsang SY; Hu T; Yang JF; Mat WK; Wang H; Xue H
BMC Cancer; 2020 Jan; 20(1):84. PubMed ID: 32005109
[TBL] [Abstract][Full Text] [Related]
3. Massive interstitial copy-neutral loss-of-heterozygosity as evidence for cancer being a disease of the DNA-damage response.
Kumar Y; Yang J; Hu T; Chen L; Xu Z; Xu L; Hu XX; Tang G; Wang JM; Li Y; Poon WS; Wan W; Zhang L; Mat WK; Pun FW; Lee P; Cheong TH; Ding X; Ng SK; Tsang SY; Chen JF; Zhang P; Li S; Wang HY; Xue H
BMC Med Genomics; 2015 Jul; 8():42. PubMed ID: 26208496
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.
Marescalco MS; Capizzi C; Condorelli DF; Barresi V
J Oral Pathol Med; 2014 Jan; 43(1):20-7. PubMed ID: 23750501
[TBL] [Abstract][Full Text] [Related]
5. Genome-Wide Copy Number Variation Detection Using NGS: Data Analysis and Interpretation.
Shen W; Szankasi P; Durtschi J; Kelley TW; Xu X
Methods Mol Biol; 2019; 1908():113-124. PubMed ID: 30649724
[TBL] [Abstract][Full Text] [Related]
6. CLImAT-HET: detecting subclonal copy number alterations and loss of heterozygosity in heterogeneous tumor samples from whole-genome sequencing data.
Yu Z; Li A; Wang M
BMC Med Genomics; 2017 Mar; 10(1):15. PubMed ID: 28298214
[TBL] [Abstract][Full Text] [Related]
7. Somatic mosaicism for copy-neutral loss of heterozygosity and DNA copy number variations in the human genome.
Žilina O; Koltšina M; Raid R; Kurg A; Tõnisson N; Salumets A
BMC Genomics; 2015 Sep; 16(1):703. PubMed ID: 26376747
[TBL] [Abstract][Full Text] [Related]
8. Whole-genome sequencing of phenotypically distinct inflammatory breast cancers reveals similar genomic alterations to non-inflammatory breast cancers.
Li X; Kumar S; Harmanci A; Li S; Kitchen RR; Zhang Y; Wali VB; Reddy SM; Woodward WA; Reuben JM; Rozowsky J; Hatzis C; Ueno NT; Krishnamurthy S; Pusztai L; Gerstein M
Genome Med; 2021 Apr; 13(1):70. PubMed ID: 33902690
[TBL] [Abstract][Full Text] [Related]
9. Genome wide analysis of DNA copy number neutral loss of heterozygosity (CNNLOH) and its relation to gene expression in esophageal squamous cell carcinoma.
Hu N; Clifford RJ; Yang HH; Wang C; Goldstein AM; Ding T; Taylor PR; Lee MP
BMC Genomics; 2010 Oct; 11():576. PubMed ID: 20955586
[TBL] [Abstract][Full Text] [Related]
10. Genomic alterations in gastric cancers discovered via whole-exome sequencing.
Zhang J; Qiu W; Liu H; Qian C; Liu D; Wang H; Hu N; Tang YT; Sun J; Shen Z
BMC Cancer; 2018 Dec; 18(1):1270. PubMed ID: 30567531
[TBL] [Abstract][Full Text] [Related]
11. Whole exome sequencing in recurrent early pregnancy loss.
Qiao Y; Wen J; Tang F; Martell S; Shomer N; Leung PC; Stephenson MD; Rajcan-Separovic E
Mol Hum Reprod; 2016 May; 22(5):364-72. PubMed ID: 26826164
[TBL] [Abstract][Full Text] [Related]
12. Technical laboratory standards for interpretation and reporting of acquired copy-number abnormalities and copy-neutral loss of heterozygosity in neoplastic disorders: a joint consensus recommendation from the American College of Medical Genetics and Genomics (ACMG) and the Cancer Genomics Consortium (CGC).
Mikhail FM; Biegel JA; Cooley LD; Dubuc AM; Hirsch B; Horner VL; Newman S; Shao L; Wolff DJ; Raca G
Genet Med; 2019 Sep; 21(9):1903-1916. PubMed ID: 31138931
[TBL] [Abstract][Full Text] [Related]
13. SCNVSim: somatic copy number variation and structure variation simulator.
Qin M; Liu B; Conroy JM; Morrison CD; Hu Q; Cheng Y; Murakami M; Odunsi AO; Johnson CS; Wei L; Liu S; Wang J
BMC Bioinformatics; 2015 Feb; 16(1):66. PubMed ID: 25886838
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous basal cell carcinosarcomas: evidence of clonality and recurrent chromosomal losses.
Harms PW; Fullen DR; Patel RM; Chang D; Shalin SC; Ma L; Wood B; Beer TW; Siddiqui J; Carskadon S; Wang M; Palanisamy N; Fisher GJ; Andea A
Hum Pathol; 2015 May; 46(5):690-7. PubMed ID: 25704628
[TBL] [Abstract][Full Text] [Related]
15. Robust identification of deletions in exome and genome sequence data based on clustering of Mendelian errors.
Manheimer KB; Patel N; Richter F; Gorham J; Tai AC; Homsy J; Boskovski MT; Parfenov M; Goldmuntz E; Chung WK; Brueckner M; Tristani-Firouzi M; Srivastava D; Seidman JG; Seidman CE; Gelb BD; Sharp AJ
Hum Mutat; 2018 Jun; 39(6):870-881. PubMed ID: 29527824
[TBL] [Abstract][Full Text] [Related]
16. Whole-genome sequencing is more powerful than whole-exome sequencing for detecting exome variants.
Belkadi A; Bolze A; Itan Y; Cobat A; Vincent QB; Antipenko A; Shang L; Boisson B; Casanova JL; Abel L
Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5473-8. PubMed ID: 25827230
[TBL] [Abstract][Full Text] [Related]
17. Whole-Genome Single Nucleotide Polymorphism Microarray for Copy Number and Loss of Heterozygosity Analysis in Tumors.
Rowsey R; Znoyko I; Wolff DJ
Methods Mol Biol; 2019; 1908():89-111. PubMed ID: 30649723
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous Detection of CNVs and SNVs Improves the Diagnostic Yield of Fetuses with Ultrasound Anomalies and Normal Karyotypes.
Qi Q; Jiang Y; Zhou X; Meng H; Hao N; Chang J; Bai J; Wang C; Wang M; Guo J; Ouyang Y; Xu Z; Xiao M; Zhang VW; Liu J
Genes (Basel); 2020 Nov; 11(12):. PubMed ID: 33255631
[TBL] [Abstract][Full Text] [Related]
19. Utilization of Whole-Exome Next-Generation Sequencing Variant Read Frequency for Detection of Lesion-Specific, Somatic Loss of Heterozygosity in a Neurofibromatosis Type 1 Cohort with Tibial Pseudarthrosis.
Margraf RL; VanSant-Webb C; Sant D; Carey J; Hanson H; D'Astous J; Viskochil D; Stevenson DA; Mao R
J Mol Diagn; 2017 May; 19(3):468-474. PubMed ID: 28433079
[TBL] [Abstract][Full Text] [Related]
20. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
